Sandoz’s stock market entry sees high hopes meet sobering reality
Sandoz’s entrance into the stock market on Wednesday faced a chillier reception than expected. The biosimilar and generic drugmaker, which recently parted ways from Swiss healthcare…
Read More...
Read More...